{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:calcium-channel-blockers",
  "owner": "cardio",
  "kind": "drug",
  "slug": "calcium-channel-blockers",
  "name": "Calcium channel blockers",
  "aliases": [
    "Calcium channel blocker",
    "Calcium antagonists"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A class of medicines that work by blocking calcium from moving into cells. The US label read for one calcium channel blocker says it may be used alone or with other blood pressure and angina medicines. It lists high blood pressure, and coronary artery disease in the forms chronic stable angina, vasospastic angina and angiographically documented disease in people without heart failure or an ejection fraction under 40%.",
  "summary_technical": "Class page. MeSH descriptor D002121 (Calcium Channel Blockers, last updated 2020-05-27) is an exact match, and its scope note gives the class description. The label read is the US prescribing label of one brand-name amlodipine besylate tablet (application NDA019787, effective 2023-02-15 in openFDA). The label describes amlodipine as a dihydropyridine calcium antagonist, so it does not stand for every member of the class. The label text read states no age range for its uses. This page gives no dose, no trial result and no guideline statement, and none of the label's warnings or interactions was recorded. Medicines of the class that have their own pages are filed under it.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D002121",
      "normalized_value": "D002121",
      "match": "exact",
      "version": "MeSH linked-data descriptor record fetched on 2026-11-09, lastUpdated 2020-05-27; the record states no yearly MeSH release",
      "label": "Calcium Channel Blockers",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels"
      ],
      "condition-area": [
        "hypertension",
        "coronary-and-vascular-disease"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "MeSH says these drugs act by selective inhibition of calcium influx through cellular membranes. A US label says the one it describes inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle."
  },
  "content_digest": "38fb7af65e3e3a53a1e86e71ecc6efa6ab3eed1f5c4b7cf4d61b0000cabf9f16",
  "review": {
    "content_digest": "38fb7af65e3e3a53a1e86e71ecc6efa6ab3eed1f5c4b7cf4d61b0000cabf9f16",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-norvasc-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:calcium-channel-blockers",
      "category": "descriptive",
      "statement": "The US label of NORVASC (amlodipine besylate tablets, Viatris Specialty LLC, application NDA019787; the version dated 2023-02-15 in openFDA) calls the medicine a calcium channel blocker that may be used on its own or in combination with other antihypertensive and antianginal agents. It lists the treatment of hypertension, and coronary artery disease in three forms: chronic stable angina, vasospastic angina, and angiographically documented coronary artery disease in patients without heart failure or an ejection fraction under 40%. MeSH describes the class as drugs that act by selective inhibition of calcium influx through cellular membranes.",
      "context": {
        "id": "cardio:ctx-fda-norvasc-label-us",
        "label": "People with hypertension or coronary artery disease, as described in the US label of a calcium channel blocker",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label: patients with hypertension, and patients with chronic stable angina, vasospastic angina, or angiographically documented coronary artery disease without heart failure or an ejection fraction under 40%.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Not stated in the passages read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Hypertension",
            "Chronic stable angina",
            "Vasospastic angina",
            "Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction under 40%"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The medicine is a dihydropyridine, so the label does not stand for every calcium channel blocker. The label text read states no age range. Contraindications, warnings, interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that call the medicine a calcium channel blocker and list hypertension and coronary artery disease.",
          "snapshot": {
            "id": "cardio:openfda-label-norvasc-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:36Z",
            "content_hash": "bf6df4ca425b576e31632a7221984d7eb04668134e654d030073338ba914819d",
            "source_effective_date": "2023-02-15",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-norvasc",
            "source_type": "regulator",
            "title": "openFDA drug label record for NORVASC (amlodipine besylate tablets), Viatris Specialty LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%227367289c-b0b0-466a-83e2-558e2985c29f%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 7367289c-b0b0-466a-83e2-558e2985c29f (manufacturer Viatris Specialty LLC, application NDA019787), returned on 2026-11-09. The label text is dated 2023-02-15 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-norvasc.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20230215.",
          "snapshot": {
            "id": "cardio:openfda-label-norvasc-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:36Z",
            "content_hash": "bf6df4ca425b576e31632a7221984d7eb04668134e654d030073338ba914819d",
            "source_effective_date": "2023-02-15",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-norvasc",
            "source_type": "regulator",
            "title": "openFDA drug label record for NORVASC (amlodipine besylate tablets), Viatris Specialty LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%227367289c-b0b0-466a-83e2-558e2985c29f%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 7367289c-b0b0-466a-83e2-558e2985c29f (manufacturer Viatris Specialty LLC, application NDA019787), returned on 2026-11-09. The label text is dated 2023-02-15 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-norvasc.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value",
          "applicability_note": "MeSH scope note: what the class does.",
          "snapshot": {
            "id": "cardio:mesh-scope-d002121-2026-10-30",
            "retrieved_at": "2026-10-30T19:49:57Z",
            "content_hash": "afa580433e9343662dc0028eebedb5b1943e77b266b29033c5597b5175cd8379",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d002121",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D002121 (Calcium Channel Blockers)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0003165",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0003165",
                "normalized_value": "M0003165",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept of descriptor D002121, retrieved 2026-10-30",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0003165 of descriptor D002121, fetched 2026-10-30. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed at research/snapshots/g2-meshc-M0003165.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "bccb92c8eff90fc062c2da40d1260b163079c373c90015adc700b769a9e5754b",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-norvasc-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "A US label lists treating high blood pressure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-norvasc-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "A US label lists coronary artery disease as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:coronary-artery-disease",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-norvasc-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "A US label lists chronic stable angina as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:stable-angina",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-norvasc-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Record on resistant high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:resistant-hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-norvasc-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Reading path on high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:reading-path-high-bp",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-norvasc-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Patient guide on high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:guide-new-high-blood-pressure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-norvasc-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Blood pressure lowering medicine, the care strategy",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:bp-lowering-medicine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:amlodipine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-17767-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[3].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:antiarrhythmic-drugs",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:diltiazem",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-3443-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:nifedipine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-7417-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[2].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:ranolazine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:verapamil",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-11170-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01120327",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01120327-2026-04-27",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01287260",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01287260-2014-01-29",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01355367",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01355367-2014-01-29",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02413515",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02413515-2017-08-04",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04141553",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04141553-2019-10-28",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04330300",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04330300-2020-06-30",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04559074",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04559074-2024-02-13",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04692467",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04692467-2024-04-09",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04790279",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04790279-2024-10-28",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05786417",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05786417-2026-04-07",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct07618806",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07618806-2026-06-01",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/calcium-channel-blockers/",
  "context_path": "api/v1/context/cardio--calcium-channel-blockers.md"
}
